Bangladesh launched its COVID-19 vaccination program in February 2021 with the ambitious aim of reaching 80% of the population with two doses. The program used a phased approach, initially targeting priority groups, and expanding eligibility over time as supply ramped up. By June 2022, the country had achieved its goal—having delivered over 270 million COVID-19 vaccine doses.
How did the Bangladesh manage to successfully deliver such an incredibly large vaccine volume in such a short period of time? What delivery strategies did the program adopt to ensure effective vaccine delivery, and what did these cost?
To address this knowledge gap, ThinkWell conducted a retrospective, bottom-up costing study to estimate the financial and economic costs of delivering COVID-19 vaccines in Bangladesh. The costing analysis was complemented with a qualitative assessment of enabling factors and operational challenges from the implementation of the C19 vaccination effort, as well as a mapping of key funding sources and funding flows.
Read the full report here!